• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) UNK HARMONYCA LIDOCAINE; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) UNK HARMONYCA LIDOCAINE; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number UNK HARMONYCA LIDO
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Hernia (2240)
Date of Event 03/26/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Continued d.10.Concomitant therapies: amlodipine, furoate, mometasone, citalopram, betaderm, and irbesartan.Continued h.6.Health effect - impact codes: f2303 clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.The event is a physiological complication and analysis of the device generally does not assist abbvie in determining a probable cause for this event.The event of hernia, deemed not device related is considered an unexpected adverse drug experience.
 
Event or Problem Description
Healthcare professional (hcp) reported a clinical patient was injected in the cheeks bilaterally with 2.3ml of harmonyca lidocaine.About one month later the patient received touch-up injections with 1.1ml of harmonyca lidocaine.The patient was concomitantly treated with topical pre-treatment anesthesia and concomitantly takes amlodipine, furoate, mometasone, citalopram, betaderm, and irbesartan.Approximately seven months and a half after the touch-up injections the patient experienced non device related ¿hernia¿.About three weeks later, patient was hospitalized and underwent a hernia surgery.Patient was also treated with hydromorphone.The event resolved the same day.This is the same event and the same patient reported under mdr id# 3005113652-2024-0011046 (abbvie complaint # (b)(4).This mdr is being submitted for the first injection.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK HARMONYCA LIDOCAINE
Common Device Name
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
Manufacturer Contact
terry ingram
2525 dupont drive
irvine, CA 92612
8479366324
MDR Report Key19409878
Report Number3005113652-2024-001104
Device Sequence Number8278005
Product Code LMH
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
-
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Reporter Type Manufacturer
Report Source Foreign,Study,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 05/28/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberUNK HARMONYCA LIDO
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Fifteen-Day
Initial Date Received by Manufacturer 05/09/2024
Initial Report FDA Received Date05/28/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
TOPICAL PRE-TREATMENT ANESTHESIA
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient SexFemale
Patient Weight73 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-